Hogy Medical Co.,Ltd. Website

Hogy Medical Co.,Ltd.

TSE-3593

Basic

  • Market Cap

    ¥95.64B

  • EV

    ¥82.05B

  • Shares Out

    24.27M

  • Revenue

    ¥39.1B

  • Employees

    —

Margins

  • Gross

    33.41%

  • EBITDA

    27.56%

  • Operating

    10.66%

  • Pre-Tax

    10.42%

  • Net

    7.17%

  • FCF

    11.33%

Returns (5Yr Avg)

  • ROA

    4.43%

  • ROTA

    5.18%

  • ROE

    5.07%

  • ROCE

    5.91%

  • ROIC

    4.95%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    ¥3,710

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    ¥19.42B

  • Net Debt

    -¥13.6B

  • Debt/Equity

    0.07

  • EBIT/Interest

    181.26

Growth (CAGR)

  • Rev 3Yr

    2.32%

  • Rev 5Yr

    1.3%

  • Rev 10Yr

    1.17%

  • Dil EPS 3Yr

    -11.02%

  • Dil EPS 5Yr

    -10.24%

  • Dil EPS 10Yr

    -4.28%

  • Rev Fwd 2Yr

    4.22%

  • EBITDA Fwd 2Yr

    0.84%

  • EPS Fwd 2Yr

    22.58%

  • EPS LT Growth Est

    4.08%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    2.06%

Select a metric from the list below to chart it

Mar '15

Mar '16

Mar '17

Mar '18

Mar '19

Mar '20

Mar '21

Mar '22

Mar '23

Mar '24

Mar '25 (E)

Mar '26 (E)

Mar '27 (E)

Metric
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24

Total Revenues

37,232

36,504

36,778

38,981

39,100

Total Revenues % Chg.

1.6%

-2%

0.8%

6%

0.3%

Cost of Goods Sold, Total

21,798

21,177

21,361

23,241

26,037

Gross Profit

15,434

15,327

15,417

15,740

13,063

Selling General & Admin Expenses, Total

9,056

8,788

8,476

8,436

8,894

Provision for Bad Debts

—

—

—

—

—

—

—

—

—

Depreciation & Amortization

1,070

906

805

669

—

Other Operating Expenses, Total

10,126

9,694

9,281

9,105

8,894

Operating Income

5,308

5,633

6,136

6,635

4,169

Interest Expense, Total

—

—

—

—

—

-1

-2

-6

-29

-23

Interest And Investment Income

140

123

84

155

307

Net Interest Expenses

139

121

78

126

284

Currency Exchange Gains (Loss)

36

10

-43

—

-37

Other Non Operating Income (Expenses)

307

223

115

-108

-171

EBT, Excl. Unusual Items

5,790

5,987

6,286

6,653

4,245

Gain (Loss) On Sale Of Investments

—

1,942

1,028

—

—

—

Gain (Loss) On Sale Of Assets

—

—

1

1

1

—

40

Asset Writedown

-9

-28

-1

-464

-209

Other Unusual Items

—

—

—

—

—

1

—

—

-1

EBT, Incl. Unusual Items

7,724

6,989

6,286

6,189

4,075

Income Tax Expense

2,235

2,060

1,951

1,904

1,282

Earnings From Continuing Operations

5,489

4,929

4,335

4,285

2,793

Minority Interest

—

—

—

—

—

40

30

35

31

11

Net Income

5,529

4,959

4,370

4,316

2,804

Net Income to Common Incl Extra Items

5,529

4,959

4,370

4,316

2,804

Net Income to Common Excl. Extra Items

5,529

4,959

4,370

4,316

2,804

Total Shares Outstanding

30.2

30.1

24.3

24.3

24.3

Weighted Avg. Shares Outstanding

30.2

30.2

28.6

24.3

24.3

Weighted Avg. Shares Outstanding Dil

30.2

30.2

28.6

24.3

24.3

EPS

183

164

153

177.9

115.5

EPS Diluted

183

164

153

177.9

115.5

EBITDA

10,591

10,182

10,251

10,252

10,776

Effective Tax Rate

28.9%

29.5%

31%

30.8%

31.5%